Bypass surgery versus endovascular interventions in severe or critical limb ischemia

Dabrh, Abd Moain Abu; Steffen, Mark W.; Asi, Noor; Undavalli, Chaitanya; Wang, Zhen; Elamin, Mohamed B.; Conte, Michael S.; Murad, M. Hassan

doi:10.1016/j.jvs.2015.07.068

Cited by 74 publications

(70 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…High-skill distal vein bypasses to the tibial [72], to the pedal [77], and up to the plantar or tarsal foot arteries [78] equally by targeting remote branches of pedal arteries in some particular cases [1,76] were successfully documented. We now know that both surgical and endovascular techniques are more likely complementary than competitive techniques since each of them holds major advantages and inherent drawbacks [1,29,30,79]. Endovascular techniques essentially provide minimal invasiveness, great accessibility, and reproducibility for one or multiple below-the-knee CTO recanalizations [1,29,[73][74][75].…”

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

“…Endovascular techniques essentially provide minimal invasiveness, great accessibility, and reproducibility for one or multiple below-the-knee CTO recanalizations [1,29,[73][74][75]. Alternatively, bypass offers a higher pressure on targeted arteries and more physiological and pulsatile flow inside collaterals around the wound zone [35,53,[77][78][79]. This particularity heightens arterial-arterial collateral shear stress and enhances rising arteriogenesis [58][59][60] toward further tissue cicatrization [1,29,35,60,72].…”

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

“…Although still heterogeneously structured [1,73,79], increasing contemporary clinical observation documents equivalent limb salvage, clinical success, and survival outcomes for bypass versus endoluminal interventions in selected groups of CLI patients [1-3, 27, 29-31, 79, 80]. Notwithstanding with initial historical considerations [79], these two strategies appear nowadays more intricate than ever inside the conceptualized "team approach" as CLI treatment [29,35].…”

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

“…Notwithstanding with initial historical considerations [79], these two strategies appear nowadays more intricate than ever inside the conceptualized "team approach" as CLI treatment [29,35].…”

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

“…Beyond striking surgical arterial reconstructions [76][77][78][79], new tapered nitinol [81], drug-eluting stents (DES) [82], and original drugeluting balloon, (DEB) [83] were imagined. Novel or redesigned directional or rotational atherectomy devices [84], together with latest "bioresorbable scaffolds" technologies [85], represent few additional of numerous achievements that challenge today ancient technical barriers [1,29,75,[81][82][83][84][85][86].…”

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

See 4 more Smart Citations

Ischemic Ulcer Healing: Does Appropriate Flow Reconstruction Stand for All That We Need?

Alexandrescu¹,

Triffaux²

2016

Wound Healing - New Insights Into Ancient Challenges

View full text Add to dashboard Cite

During the recent decades, soaring progresses in vascular disease knowledge, particularly in critical limb ischemia (CLI) treatment, enhanced novel diagnostic and interventional strategies with high serviceableness in patient's selection, arterial recanalization, and dedicated ischemic ulcer follow-up. However, despite undeniable advances in medical technology and clinical judgment, limb salvage, the ambulation recovery, and patient's survival seem only scarcely affected in this heterogeneous CLI group, particularly concerning the diabetic and renal patients. Innovative strategies such as "end artery occlusive disease" treatment or "wound-targeted revascularization" were equally proposed by following the angiosomal anatomical distribution associating individual foot collateral assessment in a unified macro-and micro-circulatory judgment. However, despite encouraging clinical results, prospective evidence still lacks on this concern. It also appears that specific wounds could not always stand for the lowest perfusion areas according to current CLI criteria, since severe neuropathy, inflammatory swelling, local infection, and skin trauma may add complementary hindrances to tissue viability.The present chapter endeavor to summarize main available treatment principles for ischemic ulcer recovery that every modern practitioner eventually disposes in an updated contemporary view."

show abstract

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

Section: Contemporary Landmarks In Ischemic Wounds Revascularizationmentioning

confidence: 99%

See 3 more Smart Citations

Ischemic Ulcer Healing: Does Appropriate Flow Reconstruction Stand for All That We Need?

Alexandrescu¹,

Triffaux²

2016

Wound Healing - New Insights Into Ancient Challenges

View full text Add to dashboard Cite

show abstract

Review of the Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Jones

Farber

2020

JAMA Surg

View full text Add to dashboard Cite

In 2010, it was estimated that more than 200 million people worldwide were living with peripheral arterial disease. Chronic limbthreatening ischemia (CLTI) represents the end stage of peripheral arterial disease, which, left untreated, incurs a risk of major amputation, approaching 25% at 1 year. Despite the global scale and severe clinical consequences of CLTI, it has been poorly defined and variably managed. Prior guidelines, such as the Trans-atlantic Intersociety Consensus Document on the Management of Peripheral Arterial Disease (TASC II), have offered treatment recommendations based on disease anatomy alone. 1 A more contemporary, nuanced definition of the problem and thorough understanding of the state of evidence are required to guide medical treatment, revascularization strategies, and future study. 2 Characteristics of the Guideline SourceThree vascular societies formed the global vascular guideline initiative: the European Society for Vascular Surgery, the Society for Vascular Surgery, and the World Federation of Vascular Societies. The writing group was composed of 58 individuals from 24 countries and multiple medical and surgical specialties. Although the 3 sponsoring societies primarily represent vascular surgeons, these guidelines were endorsed by multiple international groups representing medical and interventional specialties. All funding for the guidelines was from the sponsoring societies. Direct industry funding of the guidelines was prohibited, and industry consultants were ex-cluded from both the writing and reviewing groups. Strict limits were set for contributing authors on industry income during work on the guidelines, and conflicts of interest were reported in detail. An open comment period was observed prior to publication. Evidence BaseAuthors used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods to rate recommendation strength and quality of evidence. Final grading was determined by the guideline developers and a methodologist. Four systematic reviews were commissioned, subjected to peer review, and published in the Journal of Vascular Surgery, focusing on the natural history of CLTI, 3 nonrevascularization-based treatments, 4 and outcomes associated with revascularization. 5,6 The guidelines were published in the June 2019 issue of the

show abstract

Bypass surgery for chronic lower limb ischaemia

Antoniou

Georgiadis

Antoniou

et al. 2017

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Bypass surgery versus endovascular interventions in severe or critical limb ischemia

Abstract: Low quality of evidence due to imprecision and heterogeneity suggests that bypass surgery and endovascular approaches may have similar effect on mortality and major amputations. However, better primary and primary assisted patency can be expected with surgery.

Cited by 74 publications

References 19 publications

Ischemic Ulcer Healing: Does Appropriate Flow Reconstruction Stand for All That We Need?

Ischemic Ulcer Healing: Does Appropriate Flow Reconstruction Stand for All That We Need?

Review of the Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Bypass surgery for chronic lower limb ischaemia

Contact Info

Product

Resources

About